| Date Filed | Type | Description |
| 01/23/2023 |
4
| Whitehead Warren (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.66, valued at
$66k
|
|
| 01/23/2023 |
4
| Vincent Mark D. (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.66, valued at
$66k
|
|
| 01/23/2023 |
4
| Seizinger Bernd R. (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.66, valued at
$66k
|
|
| 01/23/2023 |
4
| Rice William G. (Chair, President & CEO) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 150,000 shares
@ $0
Granted 400,000 options to buy
@ $0.66, valued at
$264k
|
|
| 01/23/2023 |
4
| PLATZER ERICH (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.66, valued at
$66k
|
|
| 01/23/2023 |
4
| Payne Fletcher (SR VP & Chief Fin. Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 200,000 options to buy
@ $0.66, valued at
$132k
|
|
| 01/23/2023 |
4
| LEDRU PHILIPPE (Chief Commercial Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 200,000 options to buy
@ $0.66, valued at
$132k
|
|
| 01/23/2023 |
4
| BURGER DENIS R (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.66, valued at
$66k
|
|
| 01/23/2023 |
4
| Ashe Carol Gail (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.66, valued at
$66k
|
|
| 01/23/2023 |
4
| Bejar Rafael (Sr. VP, Chief Medical Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 200,000 options to buy
@ $0.66, valued at
$132k
|
|
| 09/21/2022 |
4
| Rice William G. (Chair, President & CEO) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Bought 10,000 shares
@ $0.6834, valued at
$6.8k
|
|
| 09/21/2022 |
4
| Payne Fletcher (SR VP & Chief Fin. Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Bought 10,000 shares
@ $0.6775, valued at
$6.8k
|
|
| 09/16/2022 |
4
| Seizinger Bernd R. (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.74, valued at
$37k
|
|
| 09/16/2022 |
3
| Seizinger Bernd R. (Director) has filed a Form 3 on Aptose Biosciences Inc. |
| 07/07/2022 |
4
| Rice William G. (Chair, President & CEO) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 600,000 options to buy
@ $0.81, valued at
$486k
|
|
| 06/28/2022 |
4
| Payne Fletcher (SR VP & Chief Fin. Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.8479, valued at
$847.9k
|
|
| 06/28/2022 |
3
| Payne Fletcher (SR VP & Chief Fin. Officer) has filed a Form 3 on Aptose Biosciences Inc. |
| 06/15/2022 |
4
| Loewy Caroline M (Former Director) has filed a Form 4 on Aptose Biosciences Inc. |
| 06/06/2022 |
4
| Rice William G. (Chair, President & CEO) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Bought 10,000 shares
@ $0.9681, valued at
$9.7k
|
|
| 04/14/2022 |
4
| LEDRU PHILIPPE (Chief Commercial Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 600,000 options to buy
@ $1.25, valued at
$750k
|
|
| 04/14/2022 |
3
| LEDRU PHILIPPE (Chief Commercial Officer) has filed a Form 3 on Aptose Biosciences Inc. |
| 01/20/2022 |
4
| Ashe Carol Gail (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.34, valued at
$67k
|
|
| 01/20/2022 |
4
| Rice William G. (Chair, President & CEO) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 700,000 options to buy
@ $1.34, valued at
$938k
|
|
| 01/20/2022 |
4
| Marango Jotin (Senior VP, CFO, and CBO) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 600,000 options to buy
@ $1.34, valued at
$804k
|
|
| 01/20/2022 |
4
| Bejar Rafael (Sr. VP, Chief Medical Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 600,000 options to buy
@ $1.34, valued at
$804k
|
|
| 01/20/2022 |
4
| Vincent Mark D. (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 01/20/2022 |
4
| BURGER DENIS R (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.34, valued at
$67k
|
|
| 01/20/2022 |
4
| Loewy Caroline M (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.34, valued at
$67k
|
|
| 01/20/2022 |
4
| Whitehead Warren (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 01/20/2022 |
4
| PLATZER ERICH (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.34, valued at
$67k
|
|
| 12/28/2021 |
4/A
| BURGER DENIS R (Director) has filed a Form 4 on Aptose Biosciences Inc. |
| 12/21/2021 |
4
| BURGER DENIS R (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Bought 10,000 shares
@ $1.449, valued at
$14.5k
|
|
| 12/20/2021 |
4
| PLATZER ERICH (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Bought 50,000 shares
@ $1.37, valued at
$68.5k
Bought 30,000 shares
@ $1.38, valued at
$41.4k
Bought 20,000 shares
@ $1.4, valued at
$28k
|
|
| 12/17/2021 |
4
| PLATZER ERICH (Director) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Bought 120,000 shares
@ $1.159, valued at
$139.1k
Bought 20,000 shares
@ $1.198, valued at
$24k
Bought 30,000 shares
@ $1.19, valued at
$35.7k
Bought 100,000 shares
@ $1.176, valued at
$117.6k
|
|
|